Clinical Performance Evaluation of DxN HBV Assay
Clinical Utility of the DxN HBV Assay as an Aid in the Management of HBV-Infected Individuals Undergoing Antiviral Therapy
Sponsor: Beckman Coulter, Inc.
Terminated
Business decision
Other terminated trials from Beckman Coulter, Inc.
More terminations from Beckman Coulter, Inc.
This observational or N/A phase trial investigates Hepatitis B and is currently terminated or withdrawn. Beckman Coulter, Inc. leads this study, which shows 11 recorded versions since 2014 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 6 earlier versions
-
Aug 2018 — Nov 2020 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
May 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beckman Coulter, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .